← All organizations
Children's Hospital Los Angeles
Academic/HospitalWebsite ↗
Also known as: Andrew Dietz | Angeline Nguyen | Children's Hospital Los Angeles | Children's Hospital of LA | Children's Hospital of Los Angeles (CHLA) | East Los Angeles Womens Center | Jennifer Shepherd | Michael Pulsipher, MD | Neena Kapoor, M.D.
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2011Last known activity
Nov 1, 2025
Timeline
1900s
- Jan 1, 1901
Children's Hospital Los Angeles— Founded
Drugs by trial phase (54 distinct, 35 trials)
Phase 4 (11 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (18 own, 0 via acquisition)
Phase 1 (10 own, 0 via acquisition)
Indications
Studied for
- Adenoviridae Infections
- Adrenal Hyperplasia, Congenital
- Adrenocortical Hyperfunction
- Adrenogenital Syndrome
- Anemia
- Anemia, Aplastic
- Anemia, Iron-Deficiency
- Autism Spectrum Disorder
- Autistic Disorder
- Bronchopulmonary Dysplasia
- Child Development Disorders, Pervasive
- Communicable Diseases
- Cytomegalovirus Infections
- Digestive System Diseases
- Disease
- Epstein-Barr Virus Infections
- Gastrointestinal Diseases
- Glioma
- Hemoglobinopathies
- Hemophilia A
- Hyperplasia
- Hypoplastic Left Heart Syndrome
- Immunologic Deficiency Syndromes
- Infections
- Intestinal Diseases
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myeloid, Acute
- Lymphoma
- Lymphoma, Non-Hodgkin
- Myelodysplastic Syndromes
- Neuroblastoma
- Osteopetrosis
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Recurrence
- Severe Combined Immunodeficiency
- Syndrome
- Uveitis
Recent trials (50)
- NCT03315299Lead sponsorN/A—
- NCT06934655Lead sponsorPhase 3Nov 1, 2025
- NCT06934655Sponsor investigatorPhase 3Nov 1, 2025
- NCT06934655OfficialPhase 3Nov 1, 2025
- NCT07103616OfficialPhase 4Sep 1, 2025
- NCT07103616Sponsor investigatorPhase 4Sep 1, 2025
- NCT07103616Lead sponsorPhase 4Sep 1, 2025
- NCT06413368Lead sponsorPhase 2/Phase 3Jul 1, 2024
- NCT06413368Sponsor investigatorPhase 2/Phase 3Jul 1, 2024
- NCT06413368OfficialPhase 2/Phase 3Jul 1, 2024
- NCT05929729Lead sponsorPhase 4Dec 1, 2023
- NCT05929729Overall official - principal investigatorPhase 4Dec 1, 2023
- NCT05929729Reponsible party - principal investigatorPhase 4Dec 1, 2023
- NCT06023043Reponsible party - principal investigatorPhase 4Nov 1, 2023
- NCT06023043Overall official - principal investigatorPhase 4Nov 1, 2023
Details
- Founded
- Los Angeles, US Jan 1, 1901
- Last known activity
- Nov 1, 2025